Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Richardson TX, Dallas TX, Fort Worth TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase 3, Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: Richardson TX, Dallas TX, Fort Worth TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04181060
Phase 3, Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: Richardson TX, Dallas TX, Fort Worth TX, Temple TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase 2, Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Location: Richardson TX, Dallas TX, Fort Worth TX, Lawton OK,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase 3, Recruiting
New
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M),
Location: Dallas TX, Austin TX, Fairfax VA
Sponsor: Crescent Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07909031
Phase 1, Phase 2, Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
for
Major Depressive Disorder
Location: Dallas TX, Wichita Falls TX, Oklahoma City OK,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06223880
Recruiting
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
for
Age Related Macular Degeneration (ARMD),
Location: Dallas TX
Sponsor: Aptabio Therapeutics, Inc.
Sex: All
Age: 18 - 50
Code: NCT07330674
Phase 1, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Dallas TX, Fort Worth TX, Mansfield TX,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for
Carcinoma, Non-Small-Cell Lung,
Location: Richardson TX, Dallas TX, Fort Worth TX, Houston TX,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05208762
Phase 1, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Richardson TX, Irving TX, Dallas TX, Fort Worth TX,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for
Cervical Cancer
Location: Richardson TX, Dallas TX, Arlington TX, Fort Worth TX,
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT06952660
Phase 4, Recruiting
A Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers
for
Smoking, Tobacco
Location: Fort Worth TX, Hurst TX, Houston TX, Aurora IL,
Sponsor: RAI Services Company
Sex: All
Age: 21 - 65
Code: NCT07710820
Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
for
Heart Failure NYHA Class II, Heart Failure NYHA Class III,